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After leaving the examination bed, he sat down once
again and the doctor commented on the result of the last
early cytomegalovirus antigen (p65) test, again positive
irrespective of the course of ganciclovir administered the
previous month. A further course of antiviral drug was
scheduled, then the patient was dismissed.
At this point, while the patient was crossing to the
door, the young fellow stopped the patient: “Please, Sir” –
he said – “pull down your socks!”. Two little violet nod-
ules appeared on the upper surface of the left foot (Fig. 1).
“Here you are!” – said the fellow as a good new. After the
disclosure of the two nodules, the examination of regional
lymph nodes (another very frequently skipped phase of
physical examination) becomes mandatory. In our patient
no nodes were found at the groin.
Some days after, a punch biopsy confirmed a Kaposi’s
sarcoma (KS) at the plaque stage. Immunosuppression was
lightened and the sarcoma regressed and finally disap-
peared. Finally, his graft function is still stable after reduc-
tion of immunosuppressive therapy.
Soon after the surgery his immunosuppressive treatment
(cyclosporine, azatioprine and steroids) had to be tapered
because of toxicity of calcineurine inhibitor and sub-clinical
cytomegalovirus infection. Nevertheless, two months after
the graft, he suffered from a urinary tract infection by K.
pneumoniae, treated with amoxicillin clavulanate.
Renal function was only sub-optimal due to an
unfavourable match between donor kidney and patient
body size; serum creatinine nadir was 2 mg/dl (38.1
ml/min calculated glomerular filtration rate).
The occurrence of different infections suggested over-
immunosuppression. His sexual profile was not investigat-
ed further.
As written in medical texts, lesions of KS are charac-
teristic and are not difficult to diagnose [1], but it is neces-
sary to be aware of their occurrence in a specific clinical
setting.
Comment
N. Pimpinelli, P.A. Modesti
The present report stresses two main points. The first is the
obvious, possibly negative implications of a selective, dis-
ease-oriented, physical examination, often forced by time.
The second is that diseases such as KS, often perceived as
typical of AIDS, can be shared by other conditions of
acquired immunodeficiency, particularly organ trans-
plants. KS is a relatively rare disease, yet it may cause
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Case report
D. Bonucchi, J. Piattoni, F. Ravera, A.M. Savazzi, 
G. Cappelli
A 48-year-old male patient presented at the regular follow-
up visit seven months after a successful kidney transplant.
After discussion of blood chemistries with the doctor, the
patient underwent a physical examination. As usual, he
unbuttoned his shirt and undid his trouser belt. Inspection
of the limbs, after pulling up his trousers, confirmed the
presence of ankle oedema; the graft was quite firm, with no
murmurs in the area. Blood pressure was 140/80 mmHg.
Fig. 1 Two nodular lesions of Kaposi’s sarcoma
additional immunosuppression, In addition, immunodefi-
ciency can also raise the incidence of more harmful skin
cancers, e.g., melanoma (Table 1), whose detection clearly
relies on a careful and complete clinical skin examination.
The incidence of skin cancer is increasing. In particu-
lar, based on rates from 2002–2004, the lifetime risk of
developing melanoma is 1.72%, that is 1 of 58 men and
women born today will be diagnosed with melanoma of
the skin at some time during their lifetime [2]. The
melanoma incidence continues to rise overproportionally
in men aged >50 years [3–5], and 0.88% of men will
develop melanoma of the skin between their 50th and 70th
birthdays compared to 0.51% for women [2].
Because melanoma usually begins on the surface of the
skin, it often can be detected at an early stage with a sys-
temic skin examination by a trained health care profes-
sional. Checking the skin regularly for any sign of disease
increases the chance of melanoma early detection. In par-
ticular, melanomas detected during a deliberate skin exam-
ination were thinner than those detected incidentally [6].
Although there is at present no conclusive evidence that
screening for melanoma will reduce its morbidity and mor-
tality, the US Preventive Task Force (USPTF) describes
screening as the most promising strategy, especially for
older people [7]. Screening for melanoma has the potential
to improve early diagnosis. Early diagnosis may in turn
result in improved outcome because primary tumour thick-
ness is the strongest predictor of prognosis and guides
therapy [8]. Indeed, the 5-year survival rate for stage I
melanoma is 91–95%; while it dramatically drops to
7–19% in stage IV [9].
In common clinical practice, melanoma is often detect-
ed by the patient himself. A population-based study per-
formed in Australia [6] revealed that 44% of melanomas
were detected by the patients themselves, with physicians
and partners of the patient detecting 25.3% and 18.6%,
respectively [6]. However, in the same study melanomas
detected by the patient or other layperson were more like-
ly to be thicker (>1 mm) than those detected by physicians
[6]. To improve skin self-examinations (SSE), the ABCD
acronym was developed, alerting patients to asymmetry,
border irregularity, colour variation and diameter (greater
than 6 mm) of pigmented lesions that are at risk for being
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melanomas. Taken together, these criteria have proven to
be reasonably sensitive and specific, although exceptions
exist, such as amelanotic melanomas or melanomas less
than 6 mm in diameter. Abbasi et al. [10] recommended
adding an “E” for “evolution”, denoting a change in the
size, shape, surface, colour or symptoms of the lesion.
Despite this, skin cancer primary and secondary prevention
practices are performed less frequently than other preven-
tive practices, such as breast examinations, Papanicolaou
tests, pelvic examinations and rectal examinations [11].
Most patients, including those in high-risk groups, do not
receive skin examinations as part of routine primary care
[12]. Physician attitudes toward skin cancer screening and
prevention, as well as a lack of training, knowledge and
clinical skills in the examination, have been identified as
barriers in clinical practice [11]. Because most patients
with skin lesions are seen by non-dermatologists [12], all
primary care physicians should have basic clinical educa-
tion in the diagnosis and evaluation of suspicious skin
lesions, starting in medical schools and continuing in their
CME programmes. Time spent in a dermatology clinic was
found to be a predictor of increased skill level, suggesting
that there is a role for dermatologists in teaching and pro-
moting this clinical skill, doubtless complemented by the
availability of patients with suspicious lesions. On the
basis of the same data, even a single session (1–5 h) spent
in a dermatology clinic can dramatically increase student
practice opportunities and skill levels [13]. However,
exposure to principles of primary and secondary preven-
tion of skin cancer could also be incorporated into other
clinical rotations, such as family practice, paediatrics and
general surgery [14]. In an ideal world, after a systemic
skin examination, suspicious pigmented lesions would then
be evaluated by a dermatologist, with clinical examination
possibly aided by non-invasive techniques such as der-
moscopy [15]. The issue of a potential workforce shortage
of dermatologists has been addressed [16].
Primary care physicians are in a unique position to per-
form cancer screenings. In their survey of 380 primary
care physicians, Geller et al. [17] reported that nearly 60%
routinely performed full-body examinations of high-risk
patients. The major reason why such exams were not per-
formed was lack of time. One can only empathise with a
primary doctor who also has to screen for malignancies of
the breast, colon, lung, cervix or prostate, etc. and still
finds the time for a thorough skin examination. However,
primary physicians could also teach the patient how to per-
form SSE. Screening in the form of a total body skin self-
examination is non-invasive, requires no special equip-
ment, and is reasonably cost-effective compared with
other conventional cancer screening strategies [18].
Who should be screened?
Visual examination of the skin in asymptomatic individuals
might cause overdiagnosis leading to the detection of bio-
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Table 1 Risk factors for melanoma
Personal history of melanoma
Family history of melanoma
Dysplastic nevus (atypical mole) syndrome
Many common moles (more than 50)
History of severe, blistering sunburns (especially in infancy)
Fair, freckled, always burning/never tanning skin (Fitzpatrick’s
type I skin)
Weakened immune system
logically benign disease that would otherwise go undetect-
ed. Complete skin examination should be suggested to sub-
jects with known risk factors for melanoma including per-
sonal and/or family history of melanoma, great number of
naevi, light phototype (fair or red hair, blue or green eye
colour and skin that never tans) and history of sunburns
(Table 1) [19, 20]. Very recently, the importance of five
main factors independently involved in the likelihood of
suspected melanoma have been identified (HARMM:
History of previous melanoma, Age over 50, Regular der-
matology consultation absent, Male sex, Mole changing)
[5]. Targeted screening toward those aged >50 years has
been suggested as a possible way to increase its cost-effec-
tiveness [5, 21, 22]. Although men aged >50 years make up
44% of those patients with a confirmed melanoma within
open access community screening programmes, excisions
are more commonly performed on patients aged <50 years
compared with patients aged >50 years within general prac-
tice [23]. It has to be considered that older men frequently
have lesions in difficult-to-see areas such as the scalp and
the back, and therefore may be limited in their ability to
notice any new or changing lesions themselves [5, 24].
Which factors facilitate self-screening?
Having had a previous clinical examination by a physician
was found to be the factor most strongly related to future
screening intention. In addition, several attitudinal factors
(perceived susceptibility, giving skin checks a high priori-
ty) as well as a previous history of keratinocyte carcinoma
were also associated with intention to screen [25].
How to perform skin self-examination
The National Cancer Institute gives patients specific sug-
gestions for performing a SSE [26] (Table 2).
People who think they have atypical nevi, as well as
those with any new, changing, or “ugly-looking” moles,
should point them out to the doctor.
Consequences of a screening programme
A community-based randomised screening programme was
reported to induce behaviour change in men aged >50 years
by increasing their rate of whole-body clinical skin exami-
nations 4-fold, and the rate of SSEs 2-fold [27]. Therefore
doctors may effectively change the skin-screening behav-
iour of their patients by extending them the possibility to
perform the first step of physical examination.
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Table 2 How to do a skin self-examination
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scalp and neck. A friend or relative may be able to help
inspect these areas. Use a comb or a blow dryer to help move
hair so you can see the scalp and neck better.
4. Be aware of where your moles are and how they look. By
checking your skin regularly, you will become familiar with
what your moles look like. Look for any signs of change, par-
ticularly a new black mole or a change in outline, shape, size,
colour (especially a new black area) or feel of an existing
mole. Also, note any new, unusual, or “ugly-looking” moles.
If your doctor has taken photos of your skin, compare these
pictures with the way your skin looks on self-examination.
5. Check moles carefully during times of hormone changes,
such as adolescence, pregnancy and menopause. As hormone
levels change, moles may change.
6. It may be helpful to record the dates of your skin exams and
to write notes about the way your skin looks. If you find any-
thing unusual, see your doctor right away. Remember, the ear-
lier a melanoma is found, the better the chance for a cure.
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